@prefix ns1: <http://example.org/relation/> .
@prefix ns2: <http://example.org/> .

<http://example.org/doc/samplepdf> a ns2:Document ;
    ns2:contains <http://example.org/entity/500_ml_volume_category>,
        <http://example.org/entity/60_month_EFS_AVD_measurement>,
        <http://example.org/entity/60_month_EFS_AV_2_measurement>,
        <http://example.org/entity/60_month_EFS_measure>,
        <http://example.org/entity/60_month_OS_AVD_measurement>,
        <http://example.org/entity/60_month_OS_AV_2_measurement>,
        <http://example.org/entity/60_month_OS_measure>,
        <http://example.org/entity/ACV_Person>,
        <http://example.org/entity/AMS_Person>,
        <http://example.org/entity/AREN0321_Study>,
        <http://example.org/entity/AREN0533_Study>,
        <http://example.org/entity/AREN0533_study>,
        <http://example.org/entity/AVD150_Treatment_Protocol>,
        <http://example.org/entity/AVD250_Treatment_Protocol>,
        <http://example.org/entity/AVD_500_ml_group>,
        <http://example.org/entity/AV_2_500_ml_group>,
        <http://example.org/entity/Actinomycin_D_drug>,
        <http://example.org/entity/Adult_Wilms_tumours_disease_category>,
        <http://example.org/entity/Armand_Trousseau_Hospital_Paris_Institution>,
        <http://example.org/entity/Associazione_Italiana_Ematologia_Oncologia_Pediatrica_AIEOP_Organization>,
        <http://example.org/entity/Austria_Country>,
        <http://example.org/entity/Autologous_stem_cell_rescue_ASCR_Treatment>,
        <http://example.org/entity/Azienda_Ospedaliera_Padova_Institution>,
        <http://example.org/entity/BdC_Person>,
        <http://example.org/entity/Bilateral_disease_condition>,
        <http://example.org/entity/CB_Person>,
        <http://example.org/entity/COGNWTS_study>,
        <http://example.org/entity/COG_Organization>,
        <http://example.org/entity/CR_Person>,
        <http://example.org/entity/CT_only_nodules_medical_condition>,
        <http://example.org/entity/Camptothecins_Drug_Class>,
        <http://example.org/entity/Carboplatin_Drug>,
        <http://example.org/entity/Carboplatin_drug>,
        <http://example.org/entity/Chemotherapy_resistant_disease_Condition>,
        <http://example.org/entity/Childrens_Oncology_Group_COG_organization>,
        <http://example.org/entity/Complete_remission_Response_to_treatment>,
        <http://example.org/entity/Consensus_Statement_document>,
        <http://example.org/entity/Cyclophosphamide_Drug>,
        <http://example.org/entity/Cyclophosphamide_drug>,
        <http://example.org/entity/Davila_Fajardo_author>,
        <http://example.org/entity/Doxorubicin_drug>,
        <http://example.org/entity/EFS_probability_concept>,
        <http://example.org/entity/Etoposide_Drug>,
        <http://example.org/entity/Etoposide_drug>,
        <http://example.org/entity/Europe_Region>,
        <http://example.org/entity/European_Expert_Paediatric_Oncology_Reference_Network_for_Diagnostics_and_Treatment_ExPO_r_Net_Organization>,
        <http://example.org/entity/FS_Person>,
        <http://example.org/entity/Faculty_of_Medicine_Gdansk_Institution>,
        <http://example.org/entity/Fondazione_IRCCS_Istituto_Nazionale_dei_Tumori_Milano_Institution>,
        <http://example.org/entity/Four_drug_regimen_Treatment_Protocol>,
        <http://example.org/entity/France_Country>,
        <http://example.org/entity/GLR_V_Person>,
        <http://example.org/entity/GMV_Person>,
        <http://example.org/entity/GOJ_Person>,
        <http://example.org/entity/Germany_Country>,
        <http://example.org/entity/Great_Ormond_Street_Hospital_London_Institution>,
        <http://example.org/entity/Group_AA_group_classification>,
        <http://example.org/entity/Group_BB_group_classification>,
        <http://example.org/entity/Group_CC_group_classification>,
        <http://example.org/entity/HR_measure>,
        <http://example.org/entity/HS_Person>,
        <http://example.org/entity/High_risk_disease_Disease_Classification>,
        <http://example.org/entity/Hospital_Universitario_Virgin_del_Rocio_Seville_Institution>,
        <http://example.org/entity/Hospital_Vall_dHebron_Barcelona_Institution>,
        <http://example.org/entity/HvT_Person>,
        <http://example.org/entity/IL_Person>,
        <http://example.org/entity/Iceland_Country>,
        <http://example.org/entity/Ifosfamide_Drug>,
        <http://example.org/entity/Infant_Wilms_tumours_disease_category>,
        <http://example.org/entity/Innovative_Therapies_for_Children_with_Cancer_consortium_Organization>,
        <http://example.org/entity/Intermediate_risk_disease_Disease_Classification>,
        <http://example.org/entity/International_Society_of_Paediatric_Oncology_Renal_Tumour_Study_Group_SIOPRTSG_organization>,
        <http://example.org/entity/Irinotecan_Drug>,
        <http://example.org/entity/Italy_Country>,
        <http://example.org/entity/Ivo_Leuschner_Person>,
        <http://example.org/entity/JAH_Person>,
        <http://example.org/entity/JB_Person>,
        <http://example.org/entity/JG_Person>,
        <http://example.org/entity/KP_J_Person>,
        <http://example.org/entity/Kaplan_Meier_analysis_analysis_method>,
        <http://example.org/entity/LInstitut_dH%C3%A9matologie_et_dOncologie_P%C3%A9diatrique_de_Lyon_Lyon_Institution>,
        <http://example.org/entity/LogRank_P_measure>,
        <http://example.org/entity/Low_risk_disease_Disease_Classification>,
        <http://example.org/entity/Lung_nodules_Symptom>,
        <http://example.org/entity/Lung_or_metastasis_radiotherapy_Treatment>,
        <http://example.org/entity/MG_Person>,
        <http://example.org/entity/MMvdH_E_Person>,
        <http://example.org/entity/Marciniak_Hospital_Wroclaw_Institution>,
        <http://example.org/entity/Marry_M_van_den_Heuvel_Eibrink_person>,
        <http://example.org/entity/Metastasis_surgery_Treatment>,
        <http://example.org/entity/NG_Person>,
        <http://example.org/entity/NSS_procedure>,
        <http://example.org/entity/NWTS_4_trial>,
        <http://example.org/entity/NWTS_5_trial>,
        <http://example.org/entity/National_Wilms_Tumor_Studies_Study>,
        <http://example.org/entity/National_Wilms_Tumor_Study_Group_Organization>,
        <http://example.org/entity/Natl_Wilms_Tumor_Study_Group_Organization>,
        <http://example.org/entity/Netherlands_Country>,
        <http://example.org/entity/Ninth_International_Society_of_Pediatric_Oncology_Wilms_Tumor_Trial_and_Study_Study>,
        <http://example.org/entity/OS_probability_concept>,
        <http://example.org/entity/Ospedale_Pediatrico_Bambino_Ges%C3%B9_Rome_Institution>,
        <http://example.org/entity/PC_Person>,
        <http://example.org/entity/Partial_response_Response_to_treatment>,
        <http://example.org/entity/Poland_Country>,
        <http://example.org/entity/Princess_M%C3%A1xima_Center_for_Paediatric_Oncology_institution>,
        <http://example.org/entity/Principal_investigator_Role>,
        <http://example.org/entity/Prinses_Maxima_Centrum_Utrecht_Institution>,
        <http://example.org/entity/Progressive_disease_Response_to_treatment>,
        <http://example.org/entity/Pulmonary_radiotherapy_Treatment>,
        <http://example.org/entity/RF_Person>,
        <http://example.org/entity/Relapsed_Wilms_tumour_condition>,
        <http://example.org/entity/Representative_nodule_resection_Treatment>,
        <http://example.org/entity/SIOP2001_protocol>,
        <http://example.org/entity/SIOP2001_protocol_protocol>,
        <http://example.org/entity/SIOP2001_randomized_trial_clinical_trial>,
        <http://example.org/entity/SIOP2001_trial>,
        <http://example.org/entity/SIOP9301_trial_clinical_trial>,
        <http://example.org/entity/SIOPGPOHSFOP_NWTSG_and_UKCCSG_Wilms_tumor_study_groups_Organization>,
        <http://example.org/entity/SIOPRTSG_Organization>,
        <http://example.org/entity/SIOPRTSG_organization>,
        <http://example.org/entity/SIOPRTSG_panel_organization>,
        <http://example.org/entity/SIOP_2001GPOH_Study>,
        <http://example.org/entity/SIOP_2001_trial_clinical_trial>,
        <http://example.org/entity/SIOP_9301_trial_Study>,
        <http://example.org/entity/SIOP_93_01_Study>,
        <http://example.org/entity/SIOP_9GPOH_Study>,
        <http://example.org/entity/SIOP_Organization>,
        <http://example.org/entity/SIOP_WT_2001_Study>,
        <http://example.org/entity/SIOP_database_database>,
        <http://example.org/entity/SIOP_organization>,
        <http://example.org/entity/SIOP_renal_tumour_protocol_Protocol>,
        <http://example.org/entity/Second_National_Wilms_Tumor_Study_Study>,
        <http://example.org/entity/Sixth_International_Society_of_Pediatric_Oncology_Wilms_Tumor_Trial_and_Study_Study>,
        <http://example.org/entity/Spain_Country>,
        <http://example.org/entity/St_Anna_KinderspitalCCRI_Vienna_Institution>,
        <http://example.org/entity/St_Jude_Childrens_Research_Hospital_Organization>,
        <http://example.org/entity/Stable_disease_Response_to_treatment>,
        <http://example.org/entity/Stage_IV_WT_Condition>,
        <http://example.org/entity/Stage_IV_stage>,
        <http://example.org/entity/Surgical_complete_resection_Treatment>,
        <http://example.org/entity/Third_National_Wilms_Tumor_Study_Study>,
        <http://example.org/entity/Topotecan_Drug>,
        <http://example.org/entity/UKW3_Study>,
        <http://example.org/entity/UKW3_trial_clinical_trial>,
        <http://example.org/entity/UK_Childrens_Cancer_and_Leukaemia_Group_UKCCLG_organization>,
        <http://example.org/entity/UK_Childrens_Cancer_and_Leukemia_Group_CCLG_Organization>,
        <http://example.org/entity/UK_Country>,
        <http://example.org/entity/UMBRELLA_SIOPRTSG_2016_protocol_protocol>,
        <http://example.org/entity/UMBRELLA_SIOP_RTSG_2016_protocol_Protocol>,
        <http://example.org/entity/UMBRELLA_SIOP_RTSG_2016_protocol_treatment_protocol>,
        <http://example.org/entity/UMBRELLA_protocol_Protocol>,
        <http://example.org/entity/UMBRELLA_protocol_protocol>,
        <http://example.org/entity/UMBRELLA_protocol_treatment_guideline>,
        <http://example.org/entity/UMBRELLA_protocol_treatment_protocol>,
        <http://example.org/entity/United_States_Renal_Data_System_Organization>,
        <http://example.org/entity/University_Hospital_Homburg_Homburg_Institution>,
        <http://example.org/entity/University_Hospital_of_Munich_Munich_Institution>,
        <http://example.org/entity/University_Hospital_of_Tuebingen_Tuebingen_Institution>,
        <http://example.org/entity/Very_good_partial_remission_Response_to_treatment>,
        <http://example.org/entity/Vincristine_drug>,
        <http://example.org/entity/Wilms_tumour_disease>,
        <http://example.org/entity/Wilms_tumour_treatment_Medical_Treatment>,
        <http://example.org/entity/Wilms_tumours_condition>,
        <http://example.org/entity/Wilms_tumours_disease>,
        <http://example.org/entity/actinomycin_D_drug>,
        <http://example.org/entity/actinomycin_D_medication>,
        <http://example.org/entity/anaplasia_condition>,
        <http://example.org/entity/blastemal_type_Wilms_tumours_disease_subtype>,
        <http://example.org/entity/blastemal_type_tumours_condition>,
        <http://example.org/entity/carboplatin_medication>,
        <http://example.org/entity/chemotherapy_treatment>,
        <http://example.org/entity/childhood_cancer_survival_Medical_Condition>,
        <http://example.org/entity/childhood_renal_tumours_disease>,
        <http://example.org/entity/clear_cell_sarcoma_of_the_kidney_CCSK_condition>,
        <http://example.org/entity/clear_cell_sarcoma_of_the_kidney_disease>,
        <http://example.org/entity/congenital_mesoblastic_nephroma_CMN_condition>,
        <http://example.org/entity/congenital_mesoblastic_nephroma_disease>,
        <http://example.org/entity/cumulative_doxorubicin_dose_measure>,
        <http://example.org/entity/cyclophosphamide_medication>,
        <http://example.org/entity/doxorubicin_drug>,
        <http://example.org/entity/doxorubicin_medication>,
        <http://example.org/entity/epithelial_tumour_types_condition>,
        <http://example.org/entity/etoposide_medication>,
        <http://example.org/entity/event_free_survival_outcome>,
        <http://example.org/entity/focal_anaplasia_type_tumours_condition>,
        <http://example.org/entity/high_risk_blastemal_type_Wilms_tumour_condition>,
        <http://example.org/entity/high_risk_diffuse_anaplasia_condition>,
        <http://example.org/entity/high_risk_histology_condition>,
        <http://example.org/entity/high_risk_risk_level>,
        <http://example.org/entity/intermediate_risk_histology_condition>,
        <http://example.org/entity/intermediate_risk_risk_level>,
        <http://example.org/entity/laparoscopic_surgery_procedure>,
        <http://example.org/entity/large_volume_tumours_condition>,
        <http://example.org/entity/low_risk_risk_level>,
        <http://example.org/entity/lung_irradiation_treatment>,
        <http://example.org/entity/malignant_rhabdoid_tumour_of_the_kidney_MRTK_condition>,
        <http://example.org/entity/malignant_rhabdoid_tumour_of_the_kidney_disease>,
        <http://example.org/entity/malignant_rhabdoid_tumours_disease>,
        <http://example.org/entity/metastatic_disease_condition>,
        <http://example.org/entity/minimally_invasive_surgery_procedure>,
        <http://example.org/entity/mixed_tumours_condition>,
        <http://example.org/entity/non_Wilms_tumours_disease_category>,
        <http://example.org/entity/overall_survival_outcome>,
        <http://example.org/entity/postoperative_chemotherapy_treatment_phase>,
        <http://example.org/entity/preoperative_treatment_treatment_phase>,
        <http://example.org/entity/proton_therapy_treatment>,
        <http://example.org/entity/pulmonary_metastases_condition>,
        <http://example.org/entity/radiotherapy_treatment>,
        <http://example.org/entity/reference_centres_facility>,
        <http://example.org/entity/regressive_tumours_condition>,
        <http://example.org/entity/renal_cell_carcinoma_RCC_condition>,
        <http://example.org/entity/renal_cell_carcinoma_disease>,
        <http://example.org/entity/renal_tumour_patients_group>,
        <http://example.org/entity/resection_procedure>,
        <http://example.org/entity/small_volume_tumours_condition>,
        <http://example.org/entity/stage_IV_disease_condition>,
        <http://example.org/entity/stromal_tumour_types_condition>,
        <http://example.org/entity/surgery_procedure>,
        <http://example.org/entity/surgery_treatment>,
        <http://example.org/entity/vincristine_and_actinomycin_D_only_treatment>,
        <http://example.org/entity/vincristine_and_actinomycin_D_plus_doxorubicin_treatment>,
        <http://example.org/entity/vincristine_drug>,
        <http://example.org/entity/vincristine_medication>,
        <http://example.org/entity/whole_abdominal_radiotherapy_treatment>,
        <http://example.org/entity/wwwsiop_rtsgeu_website> .

<http://example.org/entity/500_ml_entity> ns1:has_measure <http://example.org/entity/60_month_EFS_entity>,
        <http://example.org/entity/60_month_OS_entity> .

<http://example.org/entity/AVD_500_ml_entity> ns1:belongs_to <http://example.org/entity/60_month_EFS_AVD_entity>,
        <http://example.org/entity/60_month_OS_AVD_entity> .

<http://example.org/entity/AV_2_500_ml_entity> ns1:belongs_to <http://example.org/entity/60_month_EFS_AV_2_entity>,
        <http://example.org/entity/60_month_OS_AV_2_entity> .

<http://example.org/entity/Actinomycin_D_entity> ns1:component_of <http://example.org/entity/AV_2_entity> .

<http://example.org/entity/Armand_Trousseau_Hospital_Paris_entity> ns1:located_in <http://example.org/entity/France_entity> .

<http://example.org/entity/Azienda_Ospedaliera_Padova_entity> ns1:located_in <http://example.org/entity/Italy_entity> .

<http://example.org/entity/COGNWTS_trials_entity> ns1:informs <http://example.org/entity/radiotherapy_dosage_entity> .

<http://example.org/entity/Carboplatin_entity> ns1:recommended_for <http://example.org/entity/Nonresponisve_or_inoperable_tumor_treatment_entity> .

<http://example.org/entity/Chemotherapy_resistant_disease_entity> ns1:treated_by <http://example.org/entity/Camptothecins_entity> .

<http://example.org/entity/Complete_remission_entity> ns1:leads_to <http://example.org/entity/Surgical_complete_resection_entity> .

<http://example.org/entity/Consensus_Statement_entity> ns1:targets <http://example.org/entity/renal_tumour_patients_entity> .

<http://example.org/entity/Davila_Fajardo_entity> ns1:author_of <http://example.org/entity/2017_analysis_SIOP2001_entity> .

<http://example.org/entity/Doxorubicin_entity> ns1:component_of <http://example.org/entity/AVD_entity> .

<http://example.org/entity/Etoposide_entity> ns1:recommended_for <http://example.org/entity/Nonresponisve_or_inoperable_tumor_treatment_entity> .

<http://example.org/entity/European_Expert_Paediatric_Oncology_Reference_Network_for_Diagnostics_and_Treatment_ExPO_r_Net_entity> ns1:enhances_collaboration_for <http://example.org/entity/childhood_cancer_survival_entity> .

<http://example.org/entity/Faculty_of_Medicine_Gdansk_entity> ns1:located_in <http://example.org/entity/Poland_entity> .

<http://example.org/entity/Fondazione_IRCCS_Istituto_Nazionale_dei_Tumori_Milano_entity> ns1:located_in <http://example.org/entity/Italy_entity> .

<http://example.org/entity/Great_Ormond_Street_Hospital_London_entity> ns1:located_in <http://example.org/entity/UK_entity> .

<http://example.org/entity/Group_AA_entity> ns1:classification_for <http://example.org/entity/Relapsed_Wilms_tumour_entity> .

<http://example.org/entity/Group_BB_entity> ns1:classification_for <http://example.org/entity/Relapsed_Wilms_tumour_entity> .

<http://example.org/entity/Group_CC_entity> ns1:classification_for <http://example.org/entity/Relapsed_Wilms_tumour_entity> .

<http://example.org/entity/High_risk_disease_entity> ns1:treated_by <http://example.org/entity/Four_drug_regimen_entity> .

<http://example.org/entity/Hospital_Universitario_Virgin_del_Rocio_Seville_entity> ns1:located_in <http://example.org/entity/Spain_entity> .

<http://example.org/entity/Hospital_Vall_dHebron_Barcelona_entity> ns1:located_in <http://example.org/entity/Spain_entity> .

<http://example.org/entity/HvT_entity> ns1:researched_data_for <http://example.org/entity/article_entity> .

<http://example.org/entity/Infant_Wilms_tumours_entity> ns1:includes <http://example.org/entity/congenital_mesoblastic_nephroma_entity>,
        <http://example.org/entity/malignant_rhabdoid_tumours_entity> .

<http://example.org/entity/Innovative_Therapies_for_Children_with_Cancer_consortium_entity> ns1:contributes_to <http://example.org/entity/UMBRELLA_SIOP_RTSG_2016_protocol_entity> .

<http://example.org/entity/Intermediate_risk_disease_entity> ns1:treated_by <http://example.org/entity/AVD250_entity> .

<http://example.org/entity/Ivo_Leuschner_entity> ns1:contributor_to <http://example.org/entity/SIOPRTSG_entity> ;
    ns1:member_and_cochair <http://example.org/entity/SIOP_Pathology_Panel_entity> .

<http://example.org/entity/JAH_entity> ns1:colleague_of <http://example.org/entity/MMvdH_E_entity> ;
    ns1:researched_data_for <http://example.org/entity/article_entity> ;
    ns1:wrote_the_manuscript <http://example.org/entity/article_entity> .

<http://example.org/entity/LInstitut_dH%C3%A9matologie_et_dOncologie_P%C3%A9diatrique_de_Lyon_Lyon_entity> ns1:located_in <http://example.org/entity/France_entity> .

<http://example.org/entity/Low_risk_disease_entity> ns1:treated_by <http://example.org/entity/AVD150_entity> .

<http://example.org/entity/Marciniak_Hospital_Wroclaw_entity> ns1:located_in <http://example.org/entity/Poland_entity> .

<http://example.org/entity/Marry_M_van_den_Heuvel_Eibrink_entity> ns1:authored <http://example.org/entity/UMBRELLA_SIOPRTSG_2016_protocol_entity> ;
    ns1:is_affiliated_with <http://example.org/entity/Princess_M%C3%A1xima_Center_for_Paediatric_Oncology_entity> .

<http://example.org/entity/NWTS_4_entity> ns1:studies <http://example.org/entity/CT_only_nodules_entity> .

<http://example.org/entity/NWTS_5_entity> ns1:studies <http://example.org/entity/CT_only_nodules_entity> .

<http://example.org/entity/Ospedale_Pediatrico_Bambino_Ges%C3%B9_Rome_entity> ns1:located_in <http://example.org/entity/Italy_entity> .

<http://example.org/entity/Partial_response_entity> ns1:leads_to <http://example.org/entity/Representative_nodule_resection_entity> .

<http://example.org/entity/Principal_investigator_entity> ns1:advises_on <http://example.org/entity/Stage_IV_WT_entity> .

<http://example.org/entity/Prinses_Maxima_Centrum_Utrecht_entity> ns1:located_in <http://example.org/entity/Netherlands_entity> .

<http://example.org/entity/Progressive_disease_entity> ns1:leads_to <http://example.org/entity/Representative_nodule_resection_entity> .

<http://example.org/entity/SIOP2001_randomized_trial_entity> ns1:investigated <http://example.org/entity/doxorubicin_entity> .

<http://example.org/entity/SIOP2001_trial_entity> ns1:results_in_increase_for_blastemal_type <http://example.org/entity/event_free_survival_entity> .

<http://example.org/entity/SIOP9301_trial_entity> ns1:compared_with_SIOP2001 <http://example.org/entity/event_free_survival_entity> .

<http://example.org/entity/SIOP_database_entity> ns1:captures_outcomes_from <http://example.org/entity/AREN0533_entity> .

<http://example.org/entity/St_Anna_KinderspitalCCRI_Vienna_entity> ns1:located_in <http://example.org/entity/Austria_entity> .

<http://example.org/entity/Stable_disease_entity> ns1:leads_to <http://example.org/entity/Representative_nodule_resection_entity> .

<http://example.org/entity/UK_Childrens_Cancer_and_Leukaemia_Group_UKCCLG_entity> ns1:conducted <http://example.org/entity/UKW3_trial_entity> .

<http://example.org/entity/University_Hospital_Homburg_Homburg_entity> ns1:located_in <http://example.org/entity/Germany_entity> .

<http://example.org/entity/University_Hospital_of_Munich_Munich_entity> ns1:located_in <http://example.org/entity/Germany_entity> .

<http://example.org/entity/University_Hospital_of_Tuebingen_Tuebingen_entity> ns1:located_in <http://example.org/entity/Germany_entity> .

<http://example.org/entity/Very_good_partial_remission_entity> ns1:leads_to <http://example.org/entity/Surgical_complete_resection_entity> .

<http://example.org/entity/Vincristine_entity> ns1:component_of <http://example.org/entity/AV_2_entity> .

<http://example.org/entity/Wilms_tumour_in_adults_entity> ns1:treatment_involves <http://example.org/entity/chemotherapy_entity> .

<http://example.org/entity/blastemal_type_Wilms_tumours_entity> ns1:considered_in <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/blastemal_type_tumours_entity> ns1:treatment_according_to <http://example.org/entity/SIOP2001_entity> .

<http://example.org/entity/carboplatin_entity> ns1:used_for <http://example.org/entity/Adult_Wilms_tumours_entity> .

<http://example.org/entity/ccb_maria_teodora_entity> ns1:excluded_from <http://example.org/entity/post_hoc_analysis_entity> .

<http://example.org/entity/childhood_renal_tumours_entity> ns1:is_treated_by <http://example.org/entity/UMBRELLA_SIOPRTSG_2016_protocol_entity> .

<http://example.org/entity/cyclophosphamide_entity> ns1:used_for <http://example.org/entity/Adult_Wilms_tumours_entity> .

<http://example.org/entity/epithelial_tumour_types_entity> ns1:excluded_from <http://example.org/entity/post_hoc_analysis_entity> .

<http://example.org/entity/etoposide_entity> ns1:used_for <http://example.org/entity/Adult_Wilms_tumours_entity> .

<http://example.org/entity/high_risk_blastemal_type_Wilms_tumour_entity> ns1:specific_dosage_for <http://example.org/entity/radiotherapy_entity> .

<http://example.org/entity/high_risk_diffuse_anaplasia_entity> ns1:specific_dosage_for <http://example.org/entity/radiotherapy_entity> .

<http://example.org/entity/high_risk_entity> ns1:requires_specific_dosage <http://example.org/entity/lung_irradiation_entity> .

<http://example.org/entity/intermediate_risk_entity> ns1:requires_specific_dosage <http://example.org/entity/lung_irradiation_entity> .

<http://example.org/entity/intermediate_risk_histology_entity> ns1:may_avoid_if_confirmed_negative_lymph_nodes <http://example.org/entity/radiotherapy_entity> .

<http://example.org/entity/laparoscopic_surgery_entity> ns1:addressed_in <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/low_risk_entity> ns1:no_requirement_for <http://example.org/entity/radiotherapy_entity> .

<http://example.org/entity/minimally_invasive_surgery_entity> ns1:addressed_in <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/non_Wilms_tumours_entity> ns1:is_treated_by <http://example.org/entity/UMBRELLA_SIOPRTSG_2016_protocol_entity> .

<http://example.org/entity/postoperative_chemotherapy_entity> ns1:modifies <http://example.org/entity/cumulative_doxorubicin_dose_entity> .

<http://example.org/entity/proton_therapy_entity> ns1:potential_treatment_for <http://example.org/entity/Wilms_tumours_entity> .

<http://example.org/entity/pulmonary_metastases_entity> ns1:most_common_in <http://example.org/entity/stage_IV_disease_entity> .

<http://example.org/entity/radiotherapy_guidelines_entity> ns1:refined_from <http://example.org/entity/SIOP2001_entity> .

<http://example.org/entity/small_volume_tumours_entity> ns1:associated_with_higher <http://example.org/entity/event_free_survival_entity> .

<http://example.org/entity/vincristine_and_actinomycin_D_only_entity> ns1:treats <http://example.org/entity/CT_only_nodules_entity> .

<http://example.org/entity/vincristine_and_actinomycin_D_plus_doxorubicin_entity> ns1:treats <http://example.org/entity/CT_only_nodules_entity> .

<http://example.org/entity/whole_abdominal_radiotherapy_entity> ns1:indicated_for <http://example.org/entity/major_tumour_rupture_or_peritoneal_deposits_entity> .

<http://example.org/entity/500_ml_volume_category> a ns2:volume_category ;
    ns2:name "500+ ml",
        "<500 ml" .

<http://example.org/entity/60_month_EFS_AVD_entity> ns1:is_a_measure_of <http://example.org/entity/EFS_probability_entity> .

<http://example.org/entity/60_month_EFS_AVD_measurement> a ns2:measurement ;
    ns2:name "60-month EFS - AVD" .

<http://example.org/entity/60_month_EFS_AV_2_entity> ns1:is_a_measure_of <http://example.org/entity/EFS_probability_entity> .

<http://example.org/entity/60_month_EFS_AV_2_measurement> a ns2:measurement ;
    ns2:name "60-month EFS - AV-2" .

<http://example.org/entity/60_month_EFS_measure> a ns2:measure ;
    ns2:name "60-month EFS" .

<http://example.org/entity/60_month_OS_AVD_entity> ns1:is_a_measure_of <http://example.org/entity/OS_probability_entity> .

<http://example.org/entity/60_month_OS_AVD_measurement> a ns2:measurement ;
    ns2:name "60-month OS - AVD" .

<http://example.org/entity/60_month_OS_AV_2_entity> ns1:is_a_measure_of <http://example.org/entity/OS_probability_entity> .

<http://example.org/entity/60_month_OS_AV_2_measurement> a ns2:measurement ;
    ns2:name "60-month OS - AV-2" .

<http://example.org/entity/60_month_OS_measure> a ns2:measure ;
    ns2:name "60-month OS" .

<http://example.org/entity/ACV_Person> a ns2:Person ;
    ns2:name "A.C.V." .

<http://example.org/entity/AMS_Person> a ns2:Person ;
    ns2:name "A.M.S." .

<http://example.org/entity/AREN0321_Study> a ns2:Study ;
    ns2:name "AREN0321" .

<http://example.org/entity/AREN0533_Study> a ns2:Study ;
    ns2:name "AREN0533" .

<http://example.org/entity/AREN0533_entity> ns1:studies <http://example.org/entity/cumulative_doxorubicin_dose_entity> .

<http://example.org/entity/AREN0533_study> a ns2:study ;
    ns2:name "AREN0533" .

<http://example.org/entity/AVD150_Treatment_Protocol> a ns2:Treatment_Protocol ;
    ns2:name "AVD150" .

<http://example.org/entity/AVD250_Treatment_Protocol> a ns2:Treatment_Protocol ;
    ns2:name "AVD250" .

<http://example.org/entity/AVD_500_ml_group> a ns2:group ;
    ns2:name "AVD. 500+ ml",
        "AVD. <500 ml" .

<http://example.org/entity/AV_2_500_ml_group> a ns2:group ;
    ns2:name "AV-2. 500+ ml",
        "AV-2. <500 ml" .

<http://example.org/entity/Actinomycin_D_drug> a ns2:drug ;
    ns2:name "Actinomycin D" .

<http://example.org/entity/Adult_Wilms_tumours_disease_category> a ns2:disease_category ;
    ns2:name "Adult Wilms tumours" .

<http://example.org/entity/Armand_Trousseau_Hospital_Paris_Institution> a ns2:Institution ;
    ns2:name "Armand Trousseau Hospital, Paris" .

<http://example.org/entity/Associazione_Italiana_Ematologia_Oncologia_Pediatrica_AIEOP_Organization> a ns2:Organization ;
    ns2:name "Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP)" .

<http://example.org/entity/Austria_Country> a ns2:Country ;
    ns2:name "Austria" .

<http://example.org/entity/Autologous_stem_cell_rescue_ASCR_Treatment> a ns2:Treatment ;
    ns2:name "Autologous stem cell rescue (ASCR)" .

<http://example.org/entity/Azienda_Ospedaliera_Padova_Institution> a ns2:Institution ;
    ns2:name "Azienda Ospedaliera, Padova" .

<http://example.org/entity/BdC_Person> a ns2:Person ;
    ns2:name "B.d.C." .

<http://example.org/entity/Bilateral_disease_condition> a ns2:condition ;
    ns2:name "Bilateral disease" .

<http://example.org/entity/CB_Person> a ns2:Person ;
    ns2:name "C.B." .

<http://example.org/entity/COGNWTS_study> a ns2:study ;
    ns2:name "COG–NWTS" .

<http://example.org/entity/COG_Organization> a ns2:Organization ;
    ns2:name "COG" .

<http://example.org/entity/CR_Person> a ns2:Person ;
    ns2:name "C.R." .

<http://example.org/entity/CT_only_nodules_medical_condition> a ns2:medical_condition ;
    ns2:name "CT-only nodules" .

<http://example.org/entity/Camptothecins_Drug_Class> a ns2:Drug_Class ;
    ns2:name "Camptothecins" .

<http://example.org/entity/Carboplatin_Drug> a ns2:Drug ;
    ns2:name "Carboplatin" .

<http://example.org/entity/Carboplatin_drug> a ns2:drug ;
    ns2:name "Carboplatin" .

<http://example.org/entity/Chemotherapy_resistant_disease_Condition> a ns2:Condition ;
    ns2:name "Chemotherapy- resistant disease" .

<http://example.org/entity/Childrens_Oncology_Group_COG_organization> a ns2:organization ;
    ns2:name "Children's Oncology Group (COG)" .

<http://example.org/entity/Complete_remission_Response_to_treatment> a ns2:Response_to_treatment ;
    ns2:name "Complete remission" .

<http://example.org/entity/Consensus_Statement_document> a ns2:document ;
    ns2:name "Consensus Statement" .

<http://example.org/entity/Cyclophosphamide_Drug> a ns2:Drug ;
    ns2:name "Cyclophosphamide" .

<http://example.org/entity/Cyclophosphamide_drug> a ns2:drug ;
    ns2:name "Cyclophosphamide" .

<http://example.org/entity/Davila_Fajardo_author> a ns2:author ;
    ns2:name "Davila Fajardo" .

<http://example.org/entity/Doxorubicin_drug> a ns2:drug ;
    ns2:name "Doxorubicin" .

<http://example.org/entity/EFS_probability_concept> a ns2:concept ;
    ns2:name "EFS probability" .

<http://example.org/entity/Etoposide_Drug> a ns2:Drug ;
    ns2:name "Etoposide" .

<http://example.org/entity/Etoposide_drug> a ns2:drug ;
    ns2:name "Etoposide" .

<http://example.org/entity/Europe_Region> a ns2:Region ;
    ns2:name "Europe" .

<http://example.org/entity/European_Expert_Paediatric_Oncology_Reference_Network_for_Diagnostics_and_Treatment_ExPO_r_Net_Organization> a ns2:Organization ;
    ns2:name "European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment (ExPO-r-Net)" .

<http://example.org/entity/FS_Person> a ns2:Person ;
    ns2:name "F.S." .

<http://example.org/entity/Faculty_of_Medicine_Gdansk_Institution> a ns2:Institution ;
    ns2:name "Faculty of Medicine, Gdansk" .

<http://example.org/entity/Fondazione_IRCCS_Istituto_Nazionale_dei_Tumori_Milano_Institution> a ns2:Institution ;
    ns2:name "Fondazione IRCCS Istituto Nazionale dei Tumori, Milano" .

<http://example.org/entity/Four_drug_regimen_Treatment_Protocol> a ns2:Treatment_Protocol ;
    ns2:name "Four-drug regimen" .

<http://example.org/entity/Four_drug_regimen_entity> ns1:includes <http://example.org/entity/Lung_or_metastasis_radiotherapy_entity> .

<http://example.org/entity/France_Country> a ns2:Country ;
    ns2:name "France" .

<http://example.org/entity/GLR_V_Person> a ns2:Person ;
    ns2:name "G.L.R.-V." .

<http://example.org/entity/GMV_Person> a ns2:Person ;
    ns2:name "G.M.V." .

<http://example.org/entity/GOJ_Person> a ns2:Person ;
    ns2:name "G.O.J." .

<http://example.org/entity/Germany_Country> a ns2:Country ;
    ns2:name "Germany" .

<http://example.org/entity/Great_Ormond_Street_Hospital_London_Institution> a ns2:Institution ;
    ns2:name "Great Ormond Street Hospital, London" .

<http://example.org/entity/Group_AA_group_classification> a ns2:group_classification ;
    ns2:name "Group AA" .

<http://example.org/entity/Group_BB_group_classification> a ns2:group_classification ;
    ns2:name "Group BB" .

<http://example.org/entity/Group_CC_group_classification> a ns2:group_classification ;
    ns2:name "Group CC" .

<http://example.org/entity/HR_measure> a ns2:measure ;
    ns2:name "HR" .

<http://example.org/entity/HS_Person> a ns2:Person ;
    ns2:name "H.S." .

<http://example.org/entity/High_risk_disease_Disease_Classification> a ns2:Disease_Classification ;
    ns2:name "High-risk disease" .

<http://example.org/entity/Hospital_Universitario_Virgin_del_Rocio_Seville_Institution> a ns2:Institution ;
    ns2:name "Hospital Universitario Virgin del Rocio, Seville" .

<http://example.org/entity/Hospital_Vall_dHebron_Barcelona_Institution> a ns2:Institution ;
    ns2:name "Hospital Vall d’Hebron, Barcelona" .

<http://example.org/entity/HvT_Person> a ns2:Person ;
    ns2:name "H.v.T." .

<http://example.org/entity/IL_Person> a ns2:Person ;
    ns2:name "I.L." .

<http://example.org/entity/Iceland_Country> a ns2:Country ;
    ns2:name "Iceland" .

<http://example.org/entity/Ifosfamide_Drug> a ns2:Drug ;
    ns2:name "Ifosfamide" .

<http://example.org/entity/Infant_Wilms_tumours_disease_category> a ns2:disease_category ;
    ns2:name "Infant Wilms tumours" .

<http://example.org/entity/Innovative_Therapies_for_Children_with_Cancer_consortium_Organization> a ns2:Organization ;
    ns2:name "Innovative Therapies for Children with Cancer consortium" .

<http://example.org/entity/Intermediate_risk_disease_Disease_Classification> a ns2:Disease_Classification ;
    ns2:name "Intermediate-risk disease" .

<http://example.org/entity/International_Society_of_Paediatric_Oncology_Renal_Tumour_Study_Group_SIOPRTSG_organization> a ns2:organization ;
    ns2:name "International Society of Paediatric Oncology — Renal Tumour Study Group (SIOP–RTSG)" .

<http://example.org/entity/Irinotecan_Drug> a ns2:Drug ;
    ns2:name "Irinotecan" .

<http://example.org/entity/Italy_Country> a ns2:Country ;
    ns2:name "Italy" .

<http://example.org/entity/Ivo_Leuschner_Person> a ns2:Person ;
    ns2:name "Ivo Leuschner" .

<http://example.org/entity/JAH_Person> a ns2:Person ;
    ns2:name "J.A.H." .

<http://example.org/entity/JB_Person> a ns2:Person ;
    ns2:name "J.B." .

<http://example.org/entity/JG_Person> a ns2:Person ;
    ns2:name "J.G." .

<http://example.org/entity/KP_J_Person> a ns2:Person ;
    ns2:name "K.P.-J." .

<http://example.org/entity/Kaplan_Meier_analysis_analysis_method> a ns2:analysis_method ;
    ns2:name "Kaplan Meier analysis" .

<http://example.org/entity/LInstitut_dH%C3%A9matologie_et_dOncologie_P%C3%A9diatrique_de_Lyon_Lyon_Institution> a ns2:Institution ;
    ns2:name "L’Institut d’Hématologie et d’Oncologie Pédiatrique de Lyon, Lyon" .

<http://example.org/entity/LogRank_P_measure> a ns2:measure ;
    ns2:name "Log–Rank P" .

<http://example.org/entity/Low_risk_disease_Disease_Classification> a ns2:Disease_Classification ;
    ns2:name "Low-risk disease" .

<http://example.org/entity/Lung_nodules_Symptom> a ns2:Symptom ;
    ns2:name "Lung nodules" .

<http://example.org/entity/Lung_or_metastasis_radiotherapy_Treatment> a ns2:Treatment ;
    ns2:name "Lung or metastasis radiotherapy" .

<http://example.org/entity/MG_Person> a ns2:Person ;
    ns2:name "M.G." .

<http://example.org/entity/MMvdH_E_Person> a ns2:Person ;
    ns2:name "M.M.v.d.H.-E." .

<http://example.org/entity/MMvdH_E_entity> ns1:wrote_the_manuscript <http://example.org/entity/article_entity> .

<http://example.org/entity/Marciniak_Hospital_Wroclaw_Institution> a ns2:Institution ;
    ns2:name "Marciniak Hospital, Wroclaw" .

<http://example.org/entity/Marry_M_van_den_Heuvel_Eibrink_person> a ns2:person ;
    ns2:name "Marry M. van den Heuvel-Eibrink" .

<http://example.org/entity/Metastasis_surgery_Treatment> a ns2:Treatment ;
    ns2:name "Metastasis surgery" .

<http://example.org/entity/NG_Person> a ns2:Person ;
    ns2:name "N.G." .

<http://example.org/entity/NSS_entity> ns1:not_done_if_possible <http://example.org/entity/patients_entity> ;
    ns1:surgery_method_for <http://example.org/entity/Wilms_tumour_entity> .

<http://example.org/entity/NSS_procedure> a ns2:procedure ;
    ns2:name "NSS" .

<http://example.org/entity/NWTS_4_trial> a ns2:trial ;
    ns2:name "NWTS-4" .

<http://example.org/entity/NWTS_5_trial> a ns2:trial ;
    ns2:name "NWTS-5" .

<http://example.org/entity/National_Wilms_Tumor_Studies_Study> a ns2:Study ;
    ns2:name "National Wilms Tumor Studies" .

<http://example.org/entity/National_Wilms_Tumor_Study_Group_Organization> a ns2:Organization ;
    ns2:name "National Wilms Tumor Study Group" .

<http://example.org/entity/Natl_Wilms_Tumor_Study_Group_Organization> a ns2:Organization ;
    ns2:name "Natl Wilms Tumor Study Group" .

<http://example.org/entity/Netherlands_Country> a ns2:Country ;
    ns2:name "Netherlands" .

<http://example.org/entity/Ninth_International_Society_of_Pediatric_Oncology_Wilms_Tumor_Trial_and_Study_Study> a ns2:Study ;
    ns2:name "Ninth International Society of Pediatric Oncology Wilms’ Tumor Trial and Study" .

<http://example.org/entity/OS_probability_concept> a ns2:concept ;
    ns2:name "OS probability" .

<http://example.org/entity/Ospedale_Pediatrico_Bambino_Ges%C3%B9_Rome_Institution> a ns2:Institution ;
    ns2:name "Ospedale Pediatrico Bambino Gesù, Rome" .

<http://example.org/entity/PC_Person> a ns2:Person ;
    ns2:name "P.C." .

<http://example.org/entity/Partial_response_Response_to_treatment> a ns2:Response_to_treatment ;
    ns2:name "Partial response" .

<http://example.org/entity/Poland_Country> a ns2:Country ;
    ns2:name "Poland" .

<http://example.org/entity/Princess_M%C3%A1xima_Center_for_Paediatric_Oncology_institution> a ns2:institution ;
    ns2:name "Princess Máxima Center for Paediatric Oncology" .

<http://example.org/entity/Principal_investigator_Role> a ns2:Role ;
    ns2:name "Principal investigator" .

<http://example.org/entity/Prinses_Maxima_Centrum_Utrecht_Institution> a ns2:Institution ;
    ns2:name "Prinses Maxima Centrum, Utrecht" .

<http://example.org/entity/Progressive_disease_Response_to_treatment> a ns2:Response_to_treatment ;
    ns2:name "Progressive disease" .

<http://example.org/entity/Pulmonary_radiotherapy_Treatment> a ns2:Treatment ;
    ns2:name "Pulmonary radiotherapy" .

<http://example.org/entity/RF_Person> a ns2:Person ;
    ns2:name "R.F." .

<http://example.org/entity/Relapsed_Wilms_tumour_condition> a ns2:condition ;
    ns2:name "Relapsed Wilms tumour" .

<http://example.org/entity/Representative_nodule_resection_Treatment> a ns2:Treatment ;
    ns2:name "Representative nodule resection" .

<http://example.org/entity/SIOP2001_protocol> a ns2:protocol ;
    ns2:name "SIOP−2001" .

<http://example.org/entity/SIOP2001_protocol_protocol> a ns2:protocol ;
    ns2:name "SIOP−2001 protocol" .

<http://example.org/entity/SIOP2001_randomized_trial_clinical_trial> a ns2:clinical_trial ;
    ns2:name "SIOP−2001 randomized trial" .

<http://example.org/entity/SIOP2001_trial> a ns2:trial ;
    ns2:name "SIOP−2001" .

<http://example.org/entity/SIOP9301_trial_clinical_trial> a ns2:clinical_trial ;
    ns2:name "SIOP−93–01 trial" .

<http://example.org/entity/SIOPGPOHSFOP_NWTSG_and_UKCCSG_Wilms_tumor_study_groups_Organization> a ns2:Organization ;
    ns2:name "SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms tumor study groups" .

<http://example.org/entity/SIOPRTSG_Organization> a ns2:Organization ;
    ns2:name "SIOP–RTSG" .

<http://example.org/entity/SIOPRTSG_entity> ns1:aims_to_improve <http://example.org/entity/childhood_cancer_survival_entity> ;
    ns1:contributor_to_development_of <http://example.org/entity/UMBRELLA_protocol_entity> ;
    ns1:developed_classification_for <http://example.org/entity/NSS_entity> .

<http://example.org/entity/SIOPRTSG_organization> a ns2:organization ;
    ns2:name "SIOP–RTSG" .

<http://example.org/entity/SIOPRTSG_panel_organization> a ns2:organization ;
    ns2:name "SIOP−RTSG panel" .

<http://example.org/entity/SIOP_2001GPOH_Study> a ns2:Study ;
    ns2:name "SIOP 2001/GPOH" .

<http://example.org/entity/SIOP_2001_trial_clinical_trial> a ns2:clinical_trial ;
    ns2:name "SIOP-2001 trial" .

<http://example.org/entity/SIOP_9301_trial_Study> a ns2:Study ;
    ns2:name "SIOP 93–01 trial" .

<http://example.org/entity/SIOP_93_01_Study> a ns2:Study ;
    ns2:name "SIOP 93 01" .

<http://example.org/entity/SIOP_9GPOH_Study> a ns2:Study ;
    ns2:name "SIOP-9/GPOH" .

<http://example.org/entity/SIOP_Organization> a ns2:Organization ;
    ns2:name "SIOP" .

<http://example.org/entity/SIOP_WT_2001_Study> a ns2:Study ;
    ns2:name "SIOP WT 2001" .

<http://example.org/entity/SIOP_database_database> a ns2:database ;
    ns2:name "SIOP database" .

<http://example.org/entity/SIOP_organization> a ns2:organization ;
    ns2:name "SIOP" .

<http://example.org/entity/SIOP_renal_tumour_protocol_Protocol> a ns2:Protocol ;
    ns2:name "SIOP renal tumour protocol" .

<http://example.org/entity/Second_National_Wilms_Tumor_Study_Study> a ns2:Study ;
    ns2:name "Second National Wilms’ Tumor Study" .

<http://example.org/entity/Sixth_International_Society_of_Pediatric_Oncology_Wilms_Tumor_Trial_and_Study_Study> a ns2:Study ;
    ns2:name "Sixth International Society of Pediatric Oncology Wilms’ Tumor Trial and Study" .

<http://example.org/entity/Spain_Country> a ns2:Country ;
    ns2:name "Spain" .

<http://example.org/entity/St_Anna_KinderspitalCCRI_Vienna_Institution> a ns2:Institution ;
    ns2:name "St. Anna Kinderspital/CCRI, Vienna" .

<http://example.org/entity/St_Jude_Childrens_Research_Hospital_Organization> a ns2:Organization ;
    ns2:name "St. Jude Children’s Research Hospital" .

<http://example.org/entity/Stable_disease_Response_to_treatment> a ns2:Response_to_treatment ;
    ns2:name "Stable disease" .

<http://example.org/entity/Stage_IV_WT_Condition> a ns2:Condition ;
    ns2:name "Stage IV WT" .

<http://example.org/entity/Stage_IV_stage> a ns2:stage ;
    ns2:name "Stage IV" .

<http://example.org/entity/Surgical_complete_resection_Treatment> a ns2:Treatment ;
    ns2:name "Surgical complete resection" .

<http://example.org/entity/Third_National_Wilms_Tumor_Study_Study> a ns2:Study ;
    ns2:name "Third National Wilms’ Tumor Study" .

<http://example.org/entity/Topotecan_Drug> a ns2:Drug ;
    ns2:name "Topotecan" .

<http://example.org/entity/UKW3_Study> a ns2:Study ;
    ns2:name "UKW3" .

<http://example.org/entity/UKW3_trial_clinical_trial> a ns2:clinical_trial ;
    ns2:name "UKW3 trial" .

<http://example.org/entity/UKW3_trial_entity> ns1:evaluated <http://example.org/entity/actinomycin_D_entity>,
        <http://example.org/entity/vincristine_entity> .

<http://example.org/entity/UK_Childrens_Cancer_and_Leukaemia_Group_UKCCLG_organization> a ns2:organization ;
    ns2:name "UK Children's Cancer and Leukaemia Group (UKCCLG)" .

<http://example.org/entity/UK_Childrens_Cancer_and_Leukemia_Group_CCLG_Organization> a ns2:Organization ;
    ns2:name "UK Children’s Cancer and Leukemia Group (CCLG)" .

<http://example.org/entity/UK_Country> a ns2:Country ;
    ns2:name "UK" .

<http://example.org/entity/UMBRELLA_SIOPRTSG_2016_protocol_protocol> a ns2:protocol ;
    ns2:name "UMBRELLA SIOP–RTSG 2016 protocol" .

<http://example.org/entity/UMBRELLA_SIOP_RTSG_2016_protocol_Protocol> a ns2:Protocol ;
    ns2:name "UMBRELLA-SIOP-RTSG-2016 protocol" .

<http://example.org/entity/UMBRELLA_SIOP_RTSG_2016_protocol_entity> ns1:recommends_inclusion_of <http://example.org/entity/doxorubicin_entity> .

<http://example.org/entity/UMBRELLA_SIOP_RTSG_2016_protocol_treatment_protocol> a ns2:treatment_protocol ;
    ns2:name "UMBRELLA SIOP-RTSG 2016 protocol" .

<http://example.org/entity/UMBRELLA_protocol_Protocol> a ns2:Protocol ;
    ns2:name "UMBRELLA protocol" .

<http://example.org/entity/UMBRELLA_protocol_protocol> a ns2:protocol ;
    ns2:name "UMBRELLA protocol" .

<http://example.org/entity/UMBRELLA_protocol_treatment_guideline> a ns2:treatment_guideline ;
    ns2:name "UMBRELLA protocol" .

<http://example.org/entity/UMBRELLA_protocol_treatment_protocol> a ns2:treatment_protocol ;
    ns2:name "UMBRELLA protocol" .

<http://example.org/entity/United_States_Renal_Data_System_Organization> a ns2:Organization ;
    ns2:name "United States Renal Data System" .

<http://example.org/entity/University_Hospital_Homburg_Homburg_Institution> a ns2:Institution ;
    ns2:name "University Hospital Homburg, Homburg" .

<http://example.org/entity/University_Hospital_of_Munich_Munich_Institution> a ns2:Institution ;
    ns2:name "University Hospital of Munich, Munich" .

<http://example.org/entity/University_Hospital_of_Tuebingen_Tuebingen_Institution> a ns2:Institution ;
    ns2:name "University Hospital of Tuebingen, Tuebingen" .

<http://example.org/entity/Very_good_partial_remission_Response_to_treatment> a ns2:Response_to_treatment ;
    ns2:name "Very good partial remission" .

<http://example.org/entity/Vincristine_drug> a ns2:drug ;
    ns2:name "Vincristine" .

<http://example.org/entity/Wilms_tumour_disease> a ns2:disease ;
    ns2:name "Wilms tumour" .

<http://example.org/entity/Wilms_tumour_entity> ns1:is_treated_by <http://example.org/entity/UMBRELLA_SIOPRTSG_2016_protocol_entity> ;
    ns1:treatment_involves <http://example.org/entity/chemotherapy_entity>,
        <http://example.org/entity/resection_entity> .

<http://example.org/entity/Wilms_tumour_treatment_Medical_Treatment> a ns2:Medical_Treatment ;
    ns2:name "Wilms tumour treatment" .

<http://example.org/entity/Wilms_tumours_condition> a ns2:condition ;
    ns2:name "Wilms tumours" .

<http://example.org/entity/Wilms_tumours_disease> a ns2:disease ;
    ns2:name "Wilms tumours" .

<http://example.org/entity/actinomycin_D_drug> a ns2:drug ;
    ns2:name "actinomycin D" .

<http://example.org/entity/actinomycin_D_medication> a ns2:medication ;
    ns2:name "actinomycin D" .

<http://example.org/entity/anaplasia_condition> a ns2:condition ;
    ns2:name "anaplasia" .

<http://example.org/entity/blastemal_type_Wilms_tumours_disease_subtype> a ns2:disease_subtype ;
    ns2:name "blastemal-type Wilms tumours" .

<http://example.org/entity/blastemal_type_tumours_condition> a ns2:condition ;
    ns2:name "blastemal-type tumours" .

<http://example.org/entity/carboplatin_medication> a ns2:medication ;
    ns2:name "carboplatin" .

<http://example.org/entity/chemotherapy_treatment> a ns2:treatment ;
    ns2:name "chemotherapy" .

<http://example.org/entity/childhood_cancer_survival_Medical_Condition> a ns2:Medical_Condition ;
    ns2:name "childhood cancer survival" .

<http://example.org/entity/childhood_renal_tumours_disease> a ns2:disease ;
    ns2:name "childhood renal tumours" .

<http://example.org/entity/clear_cell_sarcoma_of_the_kidney_CCSK_condition> a ns2:condition ;
    ns2:name "clear cell sarcoma of the kidney (CCSK)" .

<http://example.org/entity/clear_cell_sarcoma_of_the_kidney_disease> a ns2:disease ;
    ns2:name "clear cell sarcoma of the kidney" .

<http://example.org/entity/congenital_mesoblastic_nephroma_CMN_condition> a ns2:condition ;
    ns2:name "congenital mesoblastic nephroma (CMN)" .

<http://example.org/entity/congenital_mesoblastic_nephroma_disease> a ns2:disease ;
    ns2:name "congenital mesoblastic nephroma" .

<http://example.org/entity/congenital_mesoblastic_nephroma_entity> ns1:treatment_involves <http://example.org/entity/surgery_entity> .

<http://example.org/entity/cumulative_doxorubicin_dose_measure> a ns2:measure ;
    ns2:name "cumulative doxorubicin dose" .

<http://example.org/entity/cyclophosphamide_medication> a ns2:medication ;
    ns2:name "cyclophosphamide" .

<http://example.org/entity/doxorubicin_drug> a ns2:drug ;
    ns2:name "doxorubicin" .

<http://example.org/entity/doxorubicin_medication> a ns2:medication ;
    ns2:name "doxorubicin" .

<http://example.org/entity/epithelial_tumour_types_condition> a ns2:condition ;
    ns2:name "epithelial tumour types" .

<http://example.org/entity/etoposide_medication> a ns2:medication ;
    ns2:name "etoposide" .

<http://example.org/entity/event_free_survival_outcome> a ns2:outcome ;
    ns2:name "event-free survival" .

<http://example.org/entity/focal_anaplasia_type_tumours_condition> a ns2:condition ;
    ns2:name "focal anaplasia-type tumours" .

<http://example.org/entity/high_risk_blastemal_type_Wilms_tumour_condition> a ns2:condition ;
    ns2:name "high-risk blastemal-type Wilms tumour" .

<http://example.org/entity/high_risk_diffuse_anaplasia_condition> a ns2:condition ;
    ns2:name "high-risk diffuse anaplasia" .

<http://example.org/entity/high_risk_histology_condition> a ns2:condition ;
    ns2:name "high-risk histology" .

<http://example.org/entity/high_risk_risk_level> a ns2:risk_level ;
    ns2:name "high-risk" .

<http://example.org/entity/intermediate_risk_histology_condition> a ns2:condition ;
    ns2:name "intermediate-risk histology" .

<http://example.org/entity/intermediate_risk_risk_level> a ns2:risk_level ;
    ns2:name "intermediate-risk" .

<http://example.org/entity/laparoscopic_surgery_procedure> a ns2:procedure ;
    ns2:name "laparoscopic surgery" .

<http://example.org/entity/large_volume_tumours_condition> a ns2:condition ;
    ns2:name "large-volume tumours" .

<http://example.org/entity/large_volume_tumours_entity> ns1:associated_with_lower <http://example.org/entity/event_free_survival_entity> .

<http://example.org/entity/low_risk_risk_level> a ns2:risk_level ;
    ns2:name "low-risk" .

<http://example.org/entity/lung_irradiation_treatment> a ns2:treatment ;
    ns2:name "lung irradiation" .

<http://example.org/entity/malignant_rhabdoid_tumour_of_the_kidney_MRTK_condition> a ns2:condition ;
    ns2:name "malignant rhabdoid tumour of the kidney (MRTK)" .

<http://example.org/entity/malignant_rhabdoid_tumour_of_the_kidney_disease> a ns2:disease ;
    ns2:name "malignant rhabdoid tumour of the kidney" .

<http://example.org/entity/malignant_rhabdoid_tumours_disease> a ns2:disease ;
    ns2:name "malignant rhabdoid tumours" .

<http://example.org/entity/malignant_rhabdoid_tumours_entity> ns1:requires <http://example.org/entity/more_intensive_chemotherapy_entity> .

<http://example.org/entity/metastatic_disease_condition> a ns2:condition ;
    ns2:name "metastatic disease" .

<http://example.org/entity/minimally_invasive_surgery_procedure> a ns2:procedure ;
    ns2:name "minimally invasive surgery" .

<http://example.org/entity/mixed_tumours_condition> a ns2:condition ;
    ns2:name "mixed tumours" .

<http://example.org/entity/non_Wilms_tumours_disease_category> a ns2:disease_category ;
    ns2:name "non-Wilms tumours" .

<http://example.org/entity/overall_survival_outcome> a ns2:outcome ;
    ns2:name "overall survival" .

<http://example.org/entity/postoperative_chemotherapy_treatment_phase> a ns2:treatment_phase ;
    ns2:name "postoperative chemotherapy" .

<http://example.org/entity/preoperative_treatment_entity> ns1:applies_to <http://example.org/entity/Stage_IV_entity> .

<http://example.org/entity/preoperative_treatment_treatment_phase> a ns2:treatment_phase ;
    ns2:name "preoperative treatment" .

<http://example.org/entity/proton_therapy_treatment> a ns2:treatment ;
    ns2:name "proton therapy" .

<http://example.org/entity/pulmonary_metastases_condition> a ns2:condition ;
    ns2:name "pulmonary metastases" .

<http://example.org/entity/radiotherapy_treatment> a ns2:treatment ;
    ns2:name "radiotherapy" .

<http://example.org/entity/reference_centres_facility> a ns2:facility ;
    ns2:name "reference centres" .

<http://example.org/entity/regressive_tumours_condition> a ns2:condition ;
    ns2:name "regressive tumours" .

<http://example.org/entity/renal_cell_carcinoma_RCC_condition> a ns2:condition ;
    ns2:name "renal cell carcinoma (RCC)" .

<http://example.org/entity/renal_cell_carcinoma_disease> a ns2:disease ;
    ns2:name "renal cell carcinoma" .

<http://example.org/entity/renal_tumour_patients_group> a ns2:group ;
    ns2:name "renal tumour patients" .

<http://example.org/entity/resection_procedure> a ns2:procedure ;
    ns2:name "resection" .

<http://example.org/entity/small_volume_tumours_condition> a ns2:condition ;
    ns2:name "small-volume tumours" .

<http://example.org/entity/stage_IV_disease_condition> a ns2:condition ;
    ns2:name "stage IV disease" .

<http://example.org/entity/stage_IV_disease_entity> ns1:present_in <http://example.org/entity/Wilms_tumours_entity> .

<http://example.org/entity/stromal_tumour_types_condition> a ns2:condition ;
    ns2:name "stromal tumour types" .

<http://example.org/entity/surgery_entity> ns1:performed_in <http://example.org/entity/reference_centres_entity> .

<http://example.org/entity/surgery_procedure> a ns2:procedure ;
    ns2:name "surgery" .

<http://example.org/entity/surgery_treatment> a ns2:treatment ;
    ns2:name "surgery" .

<http://example.org/entity/vincristine_and_actinomycin_D_only_treatment> a ns2:treatment ;
    ns2:name "vincristine and actinomycin D only" .

<http://example.org/entity/vincristine_and_actinomycin_D_plus_doxorubicin_treatment> a ns2:treatment ;
    ns2:name "vincristine and actinomycin D plus doxorubicin" .

<http://example.org/entity/vincristine_drug> a ns2:drug ;
    ns2:name "vincristine" .

<http://example.org/entity/vincristine_medication> a ns2:medication ;
    ns2:name "vincristine" .

<http://example.org/entity/whole_abdominal_radiotherapy_treatment> a ns2:treatment ;
    ns2:name "whole-abdominal radiotherapy" .

<http://example.org/entity/wwwsiop_rtsgeu_website> a ns2:website ;
    ns2:name "www.siop-rtsg.eu" .

<http://example.org/entity/Surgical_complete_resection_entity> ns1:followed_by <http://example.org/entity/Pulmonary_radiotherapy_entity> .

<http://example.org/entity/doxorubicin_entity> ns1:improves_outcome_for <http://example.org/entity/large_volume_tumours_entity> ;
    ns1:no_effect_on <http://example.org/entity/overall_survival_entity> ;
    ns1:used_for <http://example.org/entity/Adult_Wilms_tumours_entity> .

<http://example.org/entity/lung_irradiation_entity> ns1:recommended_for <http://example.org/entity/patients_with_viable_metastases_or_high_risk_histology_entity> .

<http://example.org/entity/Relapsed_Wilms_tumour_entity> ns1:treated_according_to <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/SIOP2001_entity> ns1:includes_regimen <http://example.org/entity/preoperative_treatment_entity> .

<http://example.org/entity/Adult_Wilms_tumours_entity> ns1:condition_affects_treatment <http://example.org/entity/anaplasia_entity> .

<http://example.org/entity/CT_only_nodules_entity> ns1:included_in <http://example.org/entity/metastatic_disease_entity> .

<http://example.org/entity/UMBRELLA_SIOPRTSG_2016_protocol_entity> ns1:is_available_on <http://example.org/entity/wwwsiop_rtsgeu_entity> ;
    ns1:is_developed_by <http://example.org/entity/International_Society_of_Paediatric_Oncology_Renal_Tumour_Study_Group_SIOPRTSG_entity> ;
    ns1:succeeds <http://example.org/entity/SIOP2001_protocol_entity> .

<http://example.org/entity/Wilms_tumours_entity> ns1:treated_with <http://example.org/entity/actinomycin_D_entity>,
        <http://example.org/entity/vincristine_entity> .

<http://example.org/entity/radiotherapy_entity> ns1:used_for <http://example.org/entity/Wilms_tumours_entity> .

<http://example.org/entity/UMBRELLA_protocol_entity> ns1:addresses <http://example.org/entity/Wilms_tumours_entity> ;
    ns1:applies_to <http://example.org/entity/Europe_entity> ;
    ns1:collaborates_with <http://example.org/entity/COG_entity> ;
    ns1:guides <http://example.org/entity/Wilms_tumour_treatment_entity> ;
    ns1:provides_guidelines_for <http://example.org/entity/radiotherapy_and_surgery_entity> ;
    ns1:refines <http://example.org/entity/SIOP2001_entity> .

